The varying efficacy and toxicity of traditional cancer therapies has driven the development
of novel target-based agents. Members of the HER ( Human Epidermal Receptor) family, in …

Thyroid nodules are common, and the accurate diagnosis of cancer or benign disease is
important for the effective clinical management of patients. Molecular markers are a helpful …

… of small-molecule cancer therapeutics. We show how chemical biology approaches offer …
drug, thereby providing a basis for increasing speed and success in cancer drug discovery. …

… For years, researchers have investigated clinical tools and molecular approaches with the …
that could predict cancer features and behavior, allowing a more tailored approach to therapy. …

… of molecular markers in stool represents a promising noninvasive approach to screen colorectal
cancer. … Because of the molecular heterogeneity of cancer, no single marker has yielded …

… The significance of these findings cannot be understated as they represented the beginning
of our molecular understanding of cancer. Prior to these discoveries the role of DNA …

… in cancer formation. In this study, our aim was to review molecular aspects of cancer. …
In this study, we reviewed cancer from the perspective of the molecular level, in order to get …

… molecular therapies (eg, temsirolimus in renal cancer and bevacizumab in liver metastases
of colorectal cancer… more personalized approach in which therapy is tailored to the molecular …

… effective for this particular form of cancer, leading to remission for most of the patients. … he
pioneered the discovery of oncogenes in human cancers. He moved to Boston University as …

… The accumulation of molecular events during cancer progression changes the signaling
homeostasis of cancer cells through mutation, altered expression, and the development of …